The findings suggested that TRIM9 was upregulated in bladder cancer patients with high clinical stages (stage III ~ IV), when compared to those from low clinical stages (stage I ~ II, Fig. 1A). The gene discussed is TRIM9; the disease is urinary bladder carcinoma.